Special Conference on Advances in Pancreatic Cancer Research, researchers from Cellectar Biosciences Inc. presented preclinical data on [225Ac]CLR-121225 (CLR-225), a novel actinium-based radio ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback